Company
BioTelemetry, Inc.
Headquarters: Malvern, PA, United States
Employees: 5
CEO: Dr. Branislav Vajdic Ph.D.
Market Cap
$56.5 Million
USD as of Jan. 1, 2025
BioTelemetry, Inc. Categories
United States Healthcare Diagnostics & ResearchUnited States Healthcare United States Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $219.88 B |
| Danaher | $177.43 B |
| Siemens Healthineers AG | $59.19 B |
| Agilent Technologies, Inc. | $43.57 B |
| Lonza Group Ltd | $41.66 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions that detect and monitor cardiac disease. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiograms machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Stocks & Indices
BioTelemetry, Inc. has the following listings and related stock indices.
Stock: NASDAQ: BEAT wb_incandescent